HealthEquity (HQY) Misses Q4 EPS by 3c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500, Dow futures muted after big bank earnings, chip slide weighs
- Oil eases as traders monitor Russian diesel deal, Saudi attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Sysco calls on Teamsters to end LA strike after economic deal reached
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
BTIG Reiterates Buy Rating on HealthEquity, Inc (HQY)
March 19, 2025 4:53 AM EDTBTIG analyst David Larsen reiterated a Buy rating and $130.00 price target on HealthEquity, Inc (NASDAQ: HQY).
The analyst comments "On Tuesday, 3/18/25 AMC, HQY reported F4Q:25 results. Total revenue of $311.8M +19% y/y was well ahead of BTIG / consensus estimates of $306.8M / $306M but adjusted EBITDA of $107.8M +9% y/y missed BTIG... More



